| Literature DB >> 26315071 |
Wen-Jing Zhu, Hai-Xia Ma, Hui-Ying Cui, Xu Lu, Ming-Jun Shao, Shuo Li, Yan-Qing Luo, Qiang Wang, Chun-Yu Xu, Dong-Qun Xu, Chuan-He Liu1, Yu-Zhi Chen.
Abstract
BACKGROUND: The prevalence of childhood asthma has been increasing in China. This study aimed to compare the prevalence, diagnosis, and treatment of asthmatic children from urban and rural areas in Beijing, China.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26315071 PMCID: PMC4733796 DOI: 10.4103/0366-6999.163381
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
The prevalence of childhood asthma in Beijing rural areas and urban areas
| Characteristics | Urban areas | Rural areas | ||||
|---|---|---|---|---|---|---|
| 95% | 95% | |||||
| Asthma | 497 (3.68) | 3.36–4.00 | 90 (1.25) | 0.99–1.51 | 100.8 | <0.001 |
| Typical asthma | 451 (3.34) | 3.03–3.62 | 60 (0.83) | 0.62–1.04 | 122.7 | <0.001 |
| CVA | 46 (0.34) | 0.24–0.43 | 30 (0.42) | 0.27–0.57 | 0.7 | 0.39 |
| ≤5 year | 139 (2.83) | 2.37–3.30 | 2 (1.33) | 0.87–1.78 | 15.9 | <0.001 |
| >5 year | 358 (4.17) | 3.75–4.59 | 58 (1.21) | 0.90–1.52 | 89.6 | <0.001 |
| Males | 345 (4.80) | 4.30–5.29 | 58 (1.45) | 1.16–1.95 | 72.9 | <0.001 |
| Females | 152 (2.40) | 2.03–2.78 | 32 (0.92) | 0.60–1.23 | 26.7 | <0.001 |
95% CI: The rate of 95% confidence intervals; CVA: Cough variant asthma.
Figure 1Percentage of previous diagnosis in asthmatic children.
Frequency of asthma episodes in children from Beijing (Median (P25–P75))
| Items | Urban areas | Rural areas | Mann–Whitney | ||
|---|---|---|---|---|---|
| Total number of wheezing | 5 (3–10) | 5 (2–10) | 20,113 | −0.750 | 0.450 |
| Number of wheezing in last year | 1 (0–2) | 1 (0–2) | 19,603 | −1.027 | 0.304 |
| Number of wheezing in the most severe year | 2 (1–4) | 2 (1–4) | 19,910 | −0.190 | 0.849 |
| Total months with wheezing in the most severe year | 1 (1–2) | 2 (1–3) | 16,220 | −2.550 | 0.011 |
Figure 2Medications used in asthmatic children. ICS: Inhaled corticosteroids; OCS: Oral corticosteroids; LTRAs: Leukotriene receptor antagonists. *P < 0.01.